drugset / Trial / NCT06419439

Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

NCT06419439 ↗

Phase 2 Recruiting 44 enrolled VA Office of Research and Development
RandomizedSequentialSingle-blindOther

Summary

This is a pilot study to evaluate the feasibility, acceptability, and safety of ketamine infusions followed by a brief behavioral intervention in Veterans with chronic low back pain and depression.

Timeline

Start
2025-12-03
Primary completion
2028-12-01
Completion
2029-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous